Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAIV protection study in UK school population
2015-003250-41Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Feb 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by UK Health Security Agency. Primary endpoint: Influenza infection determined by PCR-positive nasal swab. Started Feb 2019; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2015-003250-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003250-41.